Postmenopausal estrogen therapy and alzheimer disease: Overall negative findings

Alzheimer Disease and Associated Disorders

Volumn 20, Issue 3, 2006, Pages 141-146

  Roberts, Rosebud O ^a   Cha, Ruth H ^b   Knopman, David S ^a   Petersen, Ronald C ^a   Rocca, Walter A ^a  

^a MAYO CLINIC   (United States)

^b Department of Health Sciences Research   (United States)

Author keywords

Alzheimer disease; Case control study; Dementia; Epidemiology; Postmenopausal estrogen therapy; Smoking

Indexed keywords

ESTROGEN; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ALZHEIMER DISEASE; ARTICLE; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG USE; ESTROGEN THERAPY; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; ONSET AGE; OUTCOME ASSESSMENT; POPULATION RESEARCH; POSTMENOPAUSE; PRIORITY JOURNAL; SMOKING; UNITED STATES;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; POSTMENOPAUSE; SMOKING;

EID: 33747454964     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002093-200607000-00004     Document Type: Article

References (34)

1. Levin-Allerhand J, McEwen BS, Lominska CE, et al. Brain region-specific up-regulation of mouse apolipoprotein E by pharmacological estrogen treatments. J Neurochem. 2001;79:796-803.
2. Nathan BP, Barsukova AG, Shen F, et al. Estrogen facilitates neurite extension via apolipoprotein E in cultured adult mouse cortical neurons. Endocrinology. 2004;145:3065-3073.
3. Green PS, Simpkins JW. Neuroprotective effects of estrogens: potential mechanisms of action. Int J Devl Neurosci. 2000;18:347-358.
4. Jaffe AB, Toran-Allerand CD, Greengard P, et al. Estrogen regulates metabolism of Alzheimer amyloid β precursor protein. J Biol Chem. 1994;269:13065-13068.
5. Luine VN. Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats. Exp Neurol. 1985;89:484-490.
6. Henderson VW, Paganini-Hill A, Emanual CK, et al. Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects. Arch Neurol. 1994;51:896-900.
7. Baldereschi M, Di Carlo A, Lepore V, et al. Estrogen-replacement therapy and Alzheimer's disease in the Italian Longitudinal Study on Aging. Neurology. 1998;50:996-1002.
8. Lerner A, Koss E, Debanne S, et al. Smoking and oestrogen-replacement therapy as protective factors for Alzheimer's disease. Lancet. 1997;349:403-404.
9. Zandi PP, Carlson MC, Plassman BL, et al. Hormone replacement therapy and incidence of Alzheimer disease in older women. The Cache County Study. JAMA. 2002;288:2123-2129.
10. Paganini-Hill A, Henderson VW. Estrogen deficiency and risk of Alzheimer's disease in women. Am J Epidemiol. 1994;140:256-261.
11. Kawas C, Resnick S, Morrison A, et al. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology. 1997;48:1517-1521.
12. Waring SC, Rocca WA, Petersen RC, et al. Postmenopausal estrogen replacement therapy and risk of AD. A population-based study. Neurology. 1999;52:965-970.
13. Brenner DE, Kukull WA, Stergachis A, et al. Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: a population-based case-control study. Am J Epidemiol. 1994;140:262-267.
14. Mortel KF, Meyer JS. Lack of postmenopausal estrogen replacement therapy and the risk of dementia. J Neuropsychiatry Clin Neurosci. 1995;7:334-337.
15. Seshadri S, Zornberg GL, Derby LE, et al. Postmenopausal estrogen replacement therapy and the risk of Alzheimer disease. Arch Neurol. 2001;58:435-440.
16. Yaffe K, Sawaya G, Lieberburg I, et al. Estrogen therapy in postmenopausal women. Effects on cognitive function and dementia. JAMA. 1998;279:688-695.
17. LeBlanc ES, Janowsky J, Chan BKS, et al. Hormone replacement therapy and cognition. Systematic review and meta-analysis. JAMA. 2001;285:1489-1499.
18. Hogervorst E, Williams J, Budge M, et al. The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis. Neuroscience. 2000;101:485-512.
19. Shumaker SA, Legault C, Rapp SR, et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women. The Women's Health Initiative Memory Study: a randomized controlled trial. JAMA. 2003;289:2651-2662.
20. Shumaker SA, Legault C, Kuller L, et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women. Women's Health Initiative Memory Study. JAMA. 2004;291:2947-2958.
21. Melton LJ III. History of the Rochester Epidemiology Project. Mayo Clin Proc. 1996;71:266-274.
22. Rocca WA, Cha RH, Waring SC, et al. Incidence of dementia and Alzheimer's disease. A reanalysis of the data from Rochester, Minnesota 1975-1984. Am J Epidemiol. 1998;148:51-62.
23. Edland SD, Rocca WA, Petersen RC, et al. Dementia and Alzheimer disease incidence rates do not vary by sex in Rochester, Minn. Arch Neurol. 2002;59:1589-1593.
24. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
25. Breslow NE, Day NE. Statistical Methods in Cancer Research. Volume 1 - The Analysis of Case-control Studies. Lyon, France: International Agency for Research on Cancer; 1980.
26. Harlow BL, Signorello LB. Factors associated with early menopause. Maturitas. 2000;35:3-9.
27. Bromberger JT, Matthews KA, Kuller LH, et al. Prospective study of the determinants of age at menopause. Am J Epidemiol. 1997;145:124-133.
28. Mattison DR, Thorgeirsson SS. Smoking and industrial pollution, and their effects on menopause and ovarian cancer. Lancet. 1978;1:187-188.
29. Barbieri RL, McShane PM, Ryan KJ. Constituents of cigarette smoke inhibit human granulosa cell aromatase. Fertil Steril. 1986;46:232-236.
30. Michnovicz JJ, Hershcopf RJ, Naganuma H, et al. Increased 2-hydroxylation of estradiol as a possible mechanism for the anti-estrogenic effect of cigarette smoking. New Eng J Med. 1986;315:1305-1309.
31. McLean BK, Rubel A, Nikitovitch-Winer MB. The differential effects of exposure to tobacco smoke on the secretion of luteinizing hormone and prolactin in the proestrous rat. Endocrinology. 1977;100:1566-1570.
32. Matthews K, Cauley J, Yaffe K, et al. Estrogen replacement therapy and cognitive decline in older community women. J Am Geriatr Soc. 1999;47:518-523.
33. Sackett DL. Bias in analytic research. J Chron Dis. 1979;32:51-63.
34. Edland SD, Rocca WA, Petersen RC, et al. Dementia and Alzheimer disease incidence rates do not vary by sex in Rochester, Minn. Arch Neurol. 2002;59:1589-1593.